MoneyWorks4Me

The sales moved up 48.45% to Rs. 59482.20 millions for the March 2023 quarter as compared to Rs. 40068.80 millions during the year-ago period.The Net Loss for the quarter ended March 2023 is Rs. -10208.20 millions as compared to Net Loss of Rs. -12862.10 millions of corresponding quarter ended March 2022Operating profit surged to 24809.50 millions from the corresponding previous quarter of 13002.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 59482.20 40068.80 48.45 208121.40 155859.80 33.53 208121.40 155859.80 33.53
Other Income 1203.00 4404.90 -72.69 3292.90 11968.80 -72.49 3292.90 11968.80 -72.49
PBIDT 24809.50 13002.50 90.81 67518.90 38654.40 74.67 67518.90 38654.40 74.67
Interest 1614.50 911.90 77.05 4721.80 3881.00 21.66 4721.80 3881.00 21.66
PBDT -6182.90 -4459.00 38.66 33419.20 16568.10 101.71 33419.20 16568.10 101.71
Depreciation 4119.80 3541.40 16.33 16008.70 13499.50 18.59 16008.70 13499.50 18.59
PBT -10302.70 -8000.40 28.78 17410.50 3068.60 467.38 17410.50 3068.60 467.38
TAX -94.50 4861.70 -101.94 503.30 4068.50 -87.63 503.30 4068.50 -87.63
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -10208.20 -12862.10 -20.63 16907.20 -999.90 -1790.89 16907.20 -999.90 -1790.89
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 41.71 32.45 28.53 32.44 24.80 30.81 32.44 24.80 30.81
Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..